Navigation Links
Cell Therapeutics Receives Additional NASDAQ Notification
Date:1/26/2009

SEATTLE, Jan. 26 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Company received an Additional Staff Determination letter (the "Determination Letter") from the Listing Qualifications Staff (the "Staff") of The NASDAQ Stock Market indicating that the Company did not comply with Marketplace Rule 4350(i)(1)(C) when the Company amended the acquisition agreement with Systems Medicine, Inc. ("SMI") and issued additional common shares to SMI shareholders. Marketplace Rule 4350(i)(1)(C) requires shareholder approval for the issuance of common stock in connection with an acquisition if the issuance is greater than 20 percent of the pre-acquisition shares outstanding.

On January 6, 2009, as disclosed in the Company's Form 8-K filed with the SEC on January 8, 2009, the Company entered into the First Amendment to Acquisition Agreement (the "Amendment"), which amended the Acquisition Agreement with SMI, dated as of July 24, 2007, whereby the Company acquired SMI in a stock-for-stock merger. Pursuant to the Amendment, the "earn-out" provision of the Acquisition Agreement was amended to provide that the Company shall pay accredited SMI stockholders an immediate substitute "earn-out" payment of $5 million, to be paid in common stock at a value of $0.13 per share (the closing market price on the date of the Amendment), in lieu of the former potential milestone payments of $5 million and $10 million tied to certain FDA milestones for Brostallacin. As a result, the Company issued 38,186,911 shares of its common stock to SMI stockholders, which is in excess of 20% of the Company's pre-transaction shares outstanding as of July 24, 2007, the date of the original Acquisition Agreement.

The violation was inadvertent and unintentional. Upon learning of the Staff's position that the issuance of shares resulting from the Amendment violated Marketplace Rule 4350(i)(1)(C)
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015  Transwestern | RBJ today announces the firm brokered a ... Shire a leading biopharmaceutical company, at Two Ledgemont Center in ... Robert Richards , president, and Brian Cohen , senior ... five-floor building at 95 Hayden Ave. Photo - ...
(Date:1/22/2015)... Crystal Diagnostics (CDx) Xpress System, a rapid ... AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing E. coli ... to as STEC or the “Big-6”) as well as Escherichia ... per 325 g of raw ground beef and raw beef ...
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project ... the legal requirements around using controlled substances in pharmaceutical ... As their international operations expand and become increasingly complex, ... as a result of the first phase of the ...
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, ... Sequenom, Inc. (NASDAQ: SQNM ), the ... agreement for next generation noninvasive prenatal tests (NIPT). ... interpretation technology, called Mantis™, to advance analysis of ...
Breaking Biology Technology:Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Global Compliance Service for Controlled Substances to Expand to China 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... Current Ceo Rudi Pauwels Becomes Executive Chairman Focusing ... New Ceo   Appointment Strengthens Commercial Focus As Biocartis ... Product In 2013 Biocartis, a company ... to drive personalized medicine and improve the diagnosis of ...
... 2011 Henrik Quintel is a graduate computer ... free time working on a model that improves the understanding ... by the simulation software AMUSE from Viennese software producer LieberLieber. ... himself as a fan of Vienna: "I actually came upon ...
... 30, 2011 Palatin Technologies, Inc. (NYSE Amex: ... targeted, receptor-specific peptide therapeutics for the treatment of ... potential, today announced that Dr. Carl Spana, President ... Windhover,s Therapeutic Area Partnerships conference on Thursday, December ...
Cached Biology Technology:Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer 2Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer 3Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer 4Visionary With a Caterpillar 2Palatin Technologies to Present at Windhover's Therapeutic Area Partnerships Conference 2
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" report ... One major trend upcoming in this ... biomedical applications. Chemical sensors help in recording of patient ...
(Date:12/11/2014)... 2014 Research and Markets , ... has announced the addition of the "Biometrics Market ... One major trend emerging in this market ... systems utilize more than one characteristic of an individual ...
(Date:12/10/2014)... a leader in performance biometric data sensor technology, today ... licensees for highly accurate, clinically validated biometric technology. This ... fitness and health sectors, but first responders/military and gaming ... as useful as the biometric data it delivers. As ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... benefit from a breakthrough that enables scientists to take ... produce insulin. The research could reduce waiting times ... cell transplants. These transplants are carried out to prevent ... from low blood sugar levels. Islet cells -- ...
... the Lawrence Livermore National Laboratory (LLNL) in California have ... Thanks to its unique surface properties at nanoscale, the ... more reliable, sensitive and cost-effective. In experiments with the ... certain organic species (1,2bis(4-pyridyl)ethylene, or BPE) in a concentration ...
... ARCATA, Calif.Woodland salamanders are a viable indicator of ... U.S. Forest Service,s Pacific Southwest Research Station. ... Garth Hodgson examined two species of woodland salamanders ... Creeka disturbed old-growth redwood forest in northern California. ...
Cached Biology News:Cell study offers more diabetic patients chance of transplant 2Almost as sensitive as a dog's nose 2Almost as sensitive as a dog's nose 3Almost as sensitive as a dog's nose 4Woodland salamanders indicators of forest ecosystem recovery 2
High-throughput DNA preparation and end sequencing of BAC libraries. 3730xl DNA sequencers. LIMS tracking utilizing Geospiza's Finch system. Full-length BAC sequencing also available. Our expertise h...
... antibody is preadsorbed to remove any reactivity towards ... aqueous glycerol solution A solution in ... and Ca 2+ ), pH 7.3 (+/- 0.1), ... free) and 0.05% sodium azide A synthetic phosphorylated ...
High-throughput DNA sequencing of any library. Just give us your transformation mixture, and we'll do the rest. ABI 3730xl's yield the longest read lengths available. LIMS tracking utilizing Geospiza...
... Agencourts cDNA sequencing and finishing services ... Agencourt can perform large-scale 5' screening ... finishing. Our considerable experience with large-scale ... make Agencourt an ideal cDNA outsourcing ...
Biology Products: